AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Nano TransMed Article
PDF (2.2 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Associations of clinical features and dynamic immune response with the duration of viral RNA shedding in patients with COVID-19

Xiaohua Chen2,§, Yao Deng3,§, Qian Shen1,§, Rong Zhang4,5, Yong Qi6, Jingjing Chen7, Zequn Lu1, Lin Miao2, Jinya Ding2( ), Rong Zhong1( )
Department of Epidemiology and Biostatistics and Ministry of Education Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Department of Laboratory Medicine, General Hospital of Central Theatre Command, Wuhan 430070, China
Zhuhai Precision Medical Center, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), Zhuhai 519000, China
Department of Laboratory Medicine, General Hospital of Southern Theatre Command, Guangzhou 510010, China
Joint Expert Group for COVID-19, Wuhan Huoshenshan Hospital, Wuhan 430100, China
Medical Department General Hospital of Central Theatre Command, Wuhan 430070, China
Department of Internal Medicine at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

§ Xiaohua Chen, Yao Deng, and Qian Shen contributed equally to this work.

Show Author Information

Graphical Abstract

Abstract

Background

Clinical features and the dynamic changes of the immune response in coronavirus disease-2019 (COVID-19) patients play essential roles in the disease courses. We hypothesized that clinical features and longitudinal dynamic immune response of COVID-19 patients might be associated with viral shedding duration.

Methods

In this retrospective study, we documented 413 adult patients with laboratory-confirmed COVID-19 from Wuhan Huoshenshan Hospital. Demographic, clinical, and laboratory data were extracted from electronic medical records. Risk factors associated with viral shedding duration were examined using odds ratios (ORs) and 95% confidence intervals (CIs) in the multivariable logistic regression models.

Results

The median duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral shedding was 48 days (interquartile range, 40–58 days) among all patients. Fever symptom (OR, 2.23; 95% CI, 1.46–3.44), delayed admission after symptom onset (OR, 15.33; 95% CI, 9.14–26.65), CD8+ T cells (OR, 1.93; 95% CI, 1.10–3.44) were associated with prolonged viral shedding. In contrast, shorter viral shedding was associated with CD4+ T cells (OR, 0.38; 95% CI, 0.16–0.88), the ratios of CD4+ T cells to CD8+ T cells (OR, 0.79; 95% CI, 0.63–0.98). Longitudinal dynamic analyses demonstrate that sustained monocyte level was associated with shorter viral shedding (OR, 0.41; 95% CI, 0.22–0.76). More importantly, the associations of CD4+ T cells, CD8+ T cells, the ratio of CD4+ T cells to CD8+ T cells, and sustained monocyte level were confined to male patients.

Conclusions

Higher CD4+ T cells, sustained monocyte level, and lower CD8+ T cells might shorten the disease course. The male-specific associations supported the contribution of sex-dependent immune responses to the disease courses.

Keywords

severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)dynamic changesimmunityrisk factorsdisease course

Electronic Supplementary Material

Download File(s)
ntm-2-1-9130015_ESM.pdf (912.9 KB)

References

[1]

Zhu, N.; Zhang, D. Y.; Wang, W. L.; Li, X. W.; Yang, B.; Song, J. D.; Zhao, X.; Huang, B. Y.; Shi, W. F.; Lu, R. J. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020, 382, 727–733.
Crossref Google Scholar
[2]

Wu, Z. Y.; McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72,314 cases from the Chinese center for disease control and prevention. JAMA 2020, 323, 1239–1242.
Crossref Google Scholar
[3]

Zhou, P.; Yang, X. L.; Wang, X. G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H. R.; Zhu, Y.; Li, B.; Huang, C. L. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020, 579, 270–273.
Crossref Google Scholar
[4]

Young, B. E.; Ong, S. W. X.; Kalimuddin, S.; Low, J. G.; Tan, S. Y.; Loh, J.; Ng, O. T.; Marimuthu, K.; Ang, L. W.; Mak, T. M. et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020, 323, 1488–1494.
Crossref Google Scholar
[5]

Li, N.; Wang, X.; Lv, T. F. Prolonged SARS-CoV-2 RNA shedding: Not a rare phenomenon. J. Med. Virol. 2020, 92, 2286–2287.
Crossref Google Scholar
[6]

Le, T. Q. M.; Takemura, T.; Moi, M. L.; Nabeshima, T.; Nguyen, L. K. H.; Hoang, V. M. P.; Ung, T. H. T.; Le, T. T.; Nguyen, V. S.; Pham, H. Q. A. et al. Severe acute respiratory syndrome coronavirus 2 shedding by travelers, Vietnam, 2020. Emerg. Infect. Dis. 2020, 26, 1624–1626.
Crossref Google Scholar
[7]

Cevik, M.; Tate, M.; Lloyd, O.; Maraolo, A. E.; Schafers, J.; Ho, A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: A systematic review and meta-analysis. Lancet Microbe. 2021, 2, e13–e22.
Crossref Google Scholar
[8]

Zou, L. R.; Ruan, F.; Huang, M. X.; Liang, L. J.; Huang, H. T.; Hong, Z. S.; Yu, J. X.; Kang, M.; Song, Y. C.; Xia, J. Y. et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 2020, 382, 1177–1179.
Crossref Google Scholar
[9]

Wölfel, R.; Corman, V. M.; Guggemos, W.; Seilmaier, M.; Zange, S.; Müller, M. A.; Niemeyer, D.; Jones, T. C.; Vollmar, P.; Rothe, C. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020, 581, 465–469.
Crossref Google Scholar
[10]

van Kampen, J. J. A.; van de Vijver, D. A. M. C.; Fraaij, P. L. A.; Haagmans, B. L.; Lamers, M. M.; Okba, N.; van den Akker, J. P. C.; Endeman, H.; Gommers, D. A. M. P. J.; Cornelissen, J. J. et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat. Commun. 2021, 12, 267.
Crossref Google Scholar
[11]

Zheng, S. F.; Fan, J.; Yu, F.; Feng, B. H.; Lou, B.; Zou, Q. D.; Xie, G. L.; Lin, S.; Wang, R. N.; Yang, X. Z. et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January–March 2020: Retrospective cohort study. BMJ 2020, 369, m1443.
Crossref Google Scholar
[12]

Xu, K. J.; Chen, Y. F.; Yuan, J.; Yi, P.; Ding, C.; Wu, W. R.; Li, Y. T.; Ni, Q.; Zou, R. R.; Li, X. H. et al. Factors associated with prolonged viral RNA shedding in patients with coronavirus disease 2019 (COVID-19). Clin. Infect. Dis. 2020, 71, 799–806.
Crossref Google Scholar
[13]

Xiao, A. T.; Tong, Y. X.; Zhang, S. Profile of RT-PCR for SARS-CoV-2: A preliminary study from 56 COVID-19 patients. Clin. Infect. Dis. 2020, 71, 2249–2251.
Crossref Google Scholar
[14]

Qi, L.; Yang, Y.; Jiang, D. X.; Tu, C.; Wan, L.; Chen, X. Y.; Li, Z. H. Factors associated with the duration of viral shedding in adults with COVID-19 outside of Wuhan, China: A retrospective cohort study. Int. J. Infect. Dis. 2020, 96, 531–537.
Crossref Google Scholar
[15]

Fu, Y.; Han, P.; Zhu, R.; Bai, T.; Yi, J. H.; Zhao, X.; Tao, M. H.; Quan, R. Z.; Chen, C. Y.; Zhang, Y. et al. Risk factors for viral RNA shedding in COVID-19 patients. Eur. Respir. J. 2020, 56, 2001190.
Crossref Google Scholar
[16]

Fontana, L. M.; Villamagna, A. H.; Sikka, M. K.; McGregor, J. C. Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature. Infect. Control Hosp. Epidemiol. 2021, 42, 659–668.
Crossref Google Scholar
[17]

Zhou, M.; Yu, F. F.; Tan, L.; Zhu, Y. D.; Ma, N.; Song, L. J.; Li, Q.; Liu, Y.; Zou, Z.; Xu, T. Y.; et al. Clinical characteristics associated with long-term viral shedding in patients with coronavirus disease 2019. Am. J. Transl. Res. 2020, 12, 6954–6964.
Google Scholar
[18]

Zhou, B.; She, J. Q.; Wang, Y. D.; Ma, X. C. Duration of viral shedding of discharged patients with severe COVID-19. Clin. Infect. Dis. 2020, 71, 2240–2242.
Crossref Google Scholar
[19]

Takahashi, T.; Ellingson, M. K.; Wong, P.; Israelow, B.; Lucas, C.; Klein, J.; Silva, J.; Mao, T. Y.; Oh, J. E.; Tokuyama, M. et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 2020, 588, 315–320.
Crossref Google Scholar
[20]

Li, K. N.; Huang, B.; Wu, M.; Zhong, A. F.; Li, L.; Cai, Y.; Wang, Z. H.; Wu, L. X.; Zhu, M. Y.; Li, J. et al. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Nat. Commun. 2020, 11, 6044.
Crossref Google Scholar
[21]

Chen, Y. Z.; Zuiani, A.; Fischinger, S.; Mullur, J.; Atyeo, C.; Travers, M.; Lelis, F. J. N.; Pullen, K. M.; Martin, H.; Tong, P. et al. Quick COVID-19 healers sustain anti-SARS-CoV-2 antibody production. Cell 2020, 183, 1496–1507.e16.
Crossref Google Scholar
[22]

Grifoni, A.; Weiskopf, D.; Ramirez, S. I.; Mateus, J.; Dan, J. M.; Moderbacher, C. R.; Rawlings, S. A.; Sutherland, A.; Premkumar, L.; Jadi, R. S. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 2020, 181, 1489–501.e15.
Crossref Google Scholar
[23]

Chen, Z. Y.; John Wherry, E. T cell responses in patients with COVID-19. Nat. Rev. Immunol. 2020, 20, 529–536.
Crossref Google Scholar
[24]

de Candia, P.; Prattichizzo, F.; Garavelli, S.; Matarese, G. T cells: Warriors of SARS-CoV-2 infection. Trends Immunol. 2021, 42, 18–30.
Crossref Google Scholar
[25]

Chen, G.; Wu, D.; Guo, W.; Cao, Y.; Huang, D.; Wang, H. W.; Wang, T.; Zhang, X. Y.; Chen, H. L.; Yu, H. J. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 2020, 130, 2620–2629.
Crossref Google Scholar
[26]

Chen, J.; Lau, Y. F.; Lamirande, E. W.; Paddock, C. D.; Bartlett, J. H.; Zaki, S. R.; Subbarao, K. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J. Virol. 2010, 84, 1289–1301.
Crossref Google Scholar
[27]

Peng, Y. C.; Mentzer, A. J.; Liu, G. H.; Yao, X.; Yin, Z. X.; Dong, D. N.; Dejnirattisai, W.; Rostron, T.; Supasa, P.; Liu, C. et al. Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 2020, 21, 1336–1345.
Crossref Google Scholar
[28]

Vibholm, L. K.; Nielsen, S. S. F.; Pahus, M. H.; Frattari, G. S.; Olesen, R.; Andersen, R.; Monrad, I.; Andersen, A. H. F.; Thomsen, M. M.; Konrad, C. V. et al. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. eBioMedicine 2021, 64, 103230.
Crossref Google Scholar
[29]

Wen, W.; Su, W. R.; Tang, H.; Le, W. Q.; Zhang, X. P.; Zheng, Y. F.; Liu, X. X.; Xie, L. H.; Li, J. M.; Ye, J. G. et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020, 6, 31.
Crossref Google Scholar
[30]

Liao, M. F.; Liu, Y.; Yuan, J.; Wen, Y. L.; Xu, G.; Zhao, J. J.; Cheng, L.; Li, J. X.; Wang, X.; Wang, F. X. et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 2020, 26, 842–844.
Crossref Google Scholar
[31]

Merad, M.; Martin, J. C. Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages. Nat. Rev. Immunol. 2020, 20, 355–362.
Crossref Google Scholar
[32]

Martinez, F. O.; Combes, T. W.; Orsenigo, F.; Gordon, S. Monocyte activation in systemic Covid-19 infection: Assay and rationale. eBioMedicine 2020, 59, 102964.
Crossref Google Scholar
[33]

Zhang, D.; Guo, R.; Lei, L.; Liu, H. J.; Wang, Y. W.; Wang, Y. L.; Qian, H. B.; Dai, T. X.; Zhang, T. X.; Lai, Y. J. et al. Frontline science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. J. Leukoc. Biol. 2021, 109, 13–22.
Crossref Google Scholar
[34]

Vetter, P.; Eberhardt, C. S.; Meyer, B.; Martinez Murillo, P. A.; Torriani, G.; Pigny, F.; Lemeille, S.; Cordey, S.; Laubscher, F.; Vu, D. L. et al. Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: A case series. mSphere 2020, 5, e00827-20.
Crossref Google Scholar
[35]

Meng, Y. F.; Wu, P.; Lu, W. R.; Liu, K.; Ma, K.; Huang, L.; Cai, J. J.; Zhang, H.; Qin, Y.; Sun, H. Y. et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients. PLoS Pathog. 2020, 16, e1008520.
Crossref Google Scholar
[36]

Jin, J. M.; Bai, P.; He, W.; Wu, F.; Liu, X. F.; Han, D. M.; Liu, S.; Yang, J. K. Gender differences in patients with COVID-19: Focus on severity and mortality. Front. Public Health 2020, 8, 152.
Crossref Google Scholar
[37]

Chen, N. S.; Zhou, M.; Dong, X.; Qu, J. M.; Gong, F. Y.; Han, Y.; Qiu, Y.; Wang, J. L.; Liu, Y.; Wei, Y. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020, 395, 507–513.
Crossref Google Scholar
[38]

Ursin, R. L.; Shapiro, J. R.; Klein, S. L. Sex-biased immune responses following SARS-CoV-2 infection. Trends Microbiol. 2020, 28, 952–954.
Crossref Google Scholar
[39]

Scully, E. P.; Haverfield, J.; Ursin, R. L.; Tannenbaum, C.; Klein, S. L. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat. Rev. Immunol. 2020, 20, 442–447.
Crossref Google Scholar
[40]

Ellegren, H.; Parsch, J. The evolution of sex-biased genes and sex-biased gene expression. Nat. Rev. Genet. 2007, 8, 689–698.
Crossref Google Scholar
[41]

Ober, C.; Loisel, D. A.; Gilad, Y. Sex-specific genetic architecture of human disease. Nat. Rev. Genet. 2008, 9, 911–922.
Crossref Google Scholar
[42]

Sieurin, J.; Brandén, G.; Magnusson, C.; Hergens, M. P.; Kosidou, K. A population-based cohort study of sex and risk of severe outcomes in covid-19. Eur. J. Epidemiol. 2022, 37, 1159–1169.
Crossref Google Scholar
[43]

Zhao, G. L.; Xu, Y. Z.; Li, J.; Cui, X. L.; Tan, X. W.; Zhang, H. Y.; Dang, L. Y. Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19. Biosci. Rep. 2021, 41, BSR20202074.
Crossref Google Scholar
Nano TransMed
Volume 2 Issue 1,
March 2023
Article number: e9130015
DOI: 10.26599/NTM.2023.9130015
Cite this article:
Chen X, Deng Y, Shen Q, et al. Associations of clinical features and dynamic immune response with the duration of viral RNA shedding in patients with COVID-19. Nano TransMed, 2023, 2(1): e9130015. https://doi.org/10.26599/NTM.2023.9130015

1431

Views

145

Downloads

0

Crossref

Altmetrics
Received: 27 February 2023
Accepted: 26 March 2023
Published: 30 March 2023
© The Author(s) 2023. Nano TransMed published by Tsinghua University Press.

The articles published in this open access journal are distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Return